March 18, 2016 – Interim results from the ongoing Canagliflozin Cardiovascular Assessment Study (CANVAS) trial suggest an increased risk of amputations associated with canagliflozin.
March 18, 2016 – Interim results from the ongoing Canagliflozin Cardiovascular Assessment Study (CANVAS) trial suggest an increased risk of amputations associated with canagliflozin.